HomeBCAX • NASDAQ
add
Bicara Therapeutics Inc
Previous close
$11.45
Day range
$11.00 - $11.99
Year range
$8.91 - $28.08
Market cap
629.47M USD
Avg Volume
591.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 26.64M | 94.62% |
Net income | -20.96M | -68.46% |
Net profit margin | — | — |
Earnings per share | -0.39 | — |
EBITDA | -26.62M | -94.70% |
Effective tax rate | -0.90% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 489.71M | 112.51% |
Total assets | 510.00M | 117.96% |
Total liabilities | 18.12M | 17.11% |
Total equity | 491.88M | — |
Shares outstanding | 54.52M | — |
Price to book | 1.27 | — |
Return on assets | -12.88% | — |
Return on capital | -13.28% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -20.96M | -68.46% |
Cash from operations | -30.03M | -273.72% |
Cash from investing | -40.00K | 90.83% |
Cash from financing | -975.00K | -100.50% |
Net change in cash | -31.05M | -116.67% |
Free cash flow | -22.35M | — |
About
Founded
2018
Headquarters
Website
Employees
55
